CWBR

CohBar Stock Price

0.9498
0.0242 (2.61%)
Upgrade to Real-Time
Afterhours (Closed)
0.9498
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
CohBar Inc CWBR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0242 2.61% 0.9498 00:00:03
Close Price Low Price High Price Open Price Previous Close
0.9153 0.91 0.948 0.94 0.9256
Bid Price Ask Price Spread News
0.90 0.9849 0.0849 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
940 268,527 $ 0.9233704 $ 247,950 425,289 0.85 - 4.80
Last Trade Time Type Quantity Stock Price Currency
17:43:18 formt 250 $ 0.9498 USD

CohBar Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 55.05M 57.96M 43.93M $ - $ - -0.30 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 17.00k 3.40%

more financials information »

CohBar News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CWBR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.001.020.910.9650109335,074-0.0502-5.02%
1 Month1.001.060.910.9871481416,447-0.0502-5.02%
3 Months1.482.21970.851.14677,549-0.5302-35.82%
6 Months1.944.800.851.48449,506-0.9902-51.04%
1 Year1.554.800.851.51254,108-0.6002-38.72%
3 Years5.616810.7890.852.81147,994-4.67-83.09%
5 Years5.616810.7890.852.81147,994-4.67-83.09%

CohBar Description

CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drug such as CB4209 and CB4211, SHLP-6, SHLP-2 and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operation of the group is functioned through the region of United States.


Your Recent History
NASDAQ
CWBR
CohBar
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.